{
    "title": "A breakthrough for MS sufferers: first oral treatment 'cuts relapse rates by half'",
    "url": "https://www.dailymail.co.uk/health/article-1378362/First-pill-MS-approved-Treatment-cuts-relapse-rates-half.html",
    "date": "2011-04-19",
    "keywords": [
        "treatment",
        "ms",
        "drug",
        "relapse",
        "cent",
        "pill",
        "half",
        "condition",
        "progression",
        "disease",
        "line",
        "gap",
        "fingolimod",
        "cost",
        "myelin",
        "london",
        "share",
        "news",
        "infusion",
        "breakthrough",
        "mail",
        "reporter",
        "gmt",
        "april",
        "view",
        "sclerosis",
        "use",
        "uk",
        "today",
        "light",
        "beta",
        "interferon",
        "glatiramer",
        "acetateit",
        "guidance",
        "month",
        "institute",
        "health",
        "excellence",
        "nice",
        "effectiveness",
        "extent",
        "patient",
        "year",
        "natalizumabms",
        "bodys",
        "immune",
        "system",
        "sufferer",
        "overcame",
        "illness",
        "marathon",
        "sarcasm",
        "way",
        "dementia",
        "medicine",
        "shyness",
        "article",
        "loss",
        "britain",
        "hospitalisation",
        "nhs",
        "episodedr",
        "doug",
        "head",
        "research",
        "society",
        "licensing",
        "conditionthere",
        "handful",
        "injection",
        "availability",
        "relief",
        "therapy",
        "neurologist",
        "expert",
        "college",
        "hospital",
        "decade",
        "agofingolimod",
        "innovation",
        "option",
        "uncertainty"
    ],
    "category": [
        "health"
    ]
}